mannkind corporation danbury, ct address

Write a review. Associate Director, CMC Product Lead. Corporate Governance. Westlake Village, CA 91362, 293 Boston Post Road West MannKind Corporation, Danbury, CT 06810 For more information, go to www.AFREZZA.com or call MannKind Corp. 1-877-323-8505 This Medication Guide has been approved by the U.S. Food and Drug Administration. Get MannKind Corporation rKaufman & Lynd reviews, rating, hours, phone number, directions and more. 3.8. Willingness to travel up to 25% of the time MannKind Corporation Address Danbury, CT 06810 USA Industry Healthcare View all jobs at MannKind Corporation Report Job All Jobs Employee Communications Jobs Full-Time At MannKind our employees are our number one asset, and we continue becoming a tight-knit community where each of us plays a critical role in our collective success. Company reviews. 38 reviews. United Therapeutics Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology. Committed to diversity, at MannKind we depend on a rich blend of . Ms. Grancio will also serve as a member of the Audit Committee of the Board. Sign in. Corporate Governance. The Company also employs field sales and. (203) 207-0912. All rights reserved. Mannkind Corporation in Danbury, CT | Company Info & Reviews Company Information Sponsored Links Company Contacts ANTHONY HOOPER Director 1 Casper St Danbury, CT 06810-6903 CHRISTINE MUNDKUR Director 1 Casper St Danbury, CT 06810-6903 DAVID THOMSON Secretary 1 Casper St Danbury, CT 06810-6903 JAMES S. SHANNON Director 1 Casper St Full Prescribing Information, including BOXED WARNING, Instructions for Use, and Medication Guide can be accessed at afrezza.com. Find company research, competitor information, contact details & financial data for Mannkind Corporation of Danbury, CT. Get the latest business insights from Dun & Bradstreet. has been appointed to its Board of Directors, effectiveDecember 1, 2020. Find jobs. Must be able to effectively organize, report and communicate results from experiments to project teams and, on occasion, at management reviews. 1 Casper St Danbury, CT 06810-6903 VIEW MAP (203) 207-0912 www.mannkindcorp.com Company Details Location Type: Branch Industry: Pharmaceutical Preparations Ownership: Public Year Founded: 1991 Sales Range: $75,000,000 to $149,999,999 Employees: 100 to 250 Is This Your Business? MannKind Corporation. Claim this business. Committed to diversity, at MannKind we depend on a rich blend of ideas, backgrounds, and working styles in our quest to change the world for the better. Mr.","language":"en","releaseDate":{"dateUTC":"2020-07-20T13:00:00","date":"2020-07-20T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Alejandro Galindo Joins MannKind as Chief Commercial Officer","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17086/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/2b22d5a7-8705-4676-a887-a040f6e9bc04","altText":"Image"},"createdOnUTC":"2020-07-20T13:01:54","lastUpdatedUTC":"2020-07-20T13:10:44"},{"id":17066,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-june-2020-lytham-partners-virtual"},"title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 17, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) announced today that it will be featured in a virtual presentation and fireside chat at the June 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, June 24, 2020 at 12 pm ET ( 9 am","language":"en","releaseDate":{"dateUTC":"2020-06-17T21:00:00","date":"2020-06-17T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-17T21:00:44","lastUpdatedUTC":"2020-06-17T21:00:44"},{"id":17051,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17051","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-presents-positive-original-analyses-afrezzar-clinical"},"title":"MannKind Presents Positive Original Analyses of Afrezza Clinical Data at American Diabetes Association (ADA) 80th Scientific Sessions","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 15, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that new data from clinical studies of Afrezza (insulin human) Inhalation Powder was presented at the American Diabetes Associations 80th Scientific Sessions , June 12-16, 2020 . About this job. ","language":"en","releaseDate":{"dateUTC":"2020-02-20T14:00:00","date":"2020-02-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16941/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/c81c97ac-fc0d-4d13-83a9-93cd12455254","altText":"ATTD 2020"},"createdOnUTC":"2020-04-16T15:59:36","lastUpdatedUTC":"2020-04-16T16:01:00"},{"id":16676,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/afrezzar-insulin-human-inhalation-powder-receives-pricing"},"title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Jan. 06, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that its Brazilian partner, Biomm S.A. , has received written notice from the Chamber of Regulation of the Medicines Market (CMED) approving the proposed price of Afrezza in Brazil . Ms.","language":"en","releaseDate":{"dateUTC":"2020-03-24T13:00:00","date":"2020-03-24T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Jennifer Grancio Appointed to MannKind Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16856/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/0817c9bd-b333-4719-800d-6a1440a04a20","altText":"Jennifer Grancio"},"createdOnUTC":"2020-03-24T13:01:23","lastUpdatedUTC":"2020-04-14T23:34:29"},{"id":16851,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16851","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-refocuses-pipeline-resources-response-covid-19-pandemic"},"title":"MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , March 17, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products, today announced that it is adjusting research and development resources that were reserved for its","language":"en","releaseDate":{"dateUTC":"2020-03-17T13:00:00","date":"2020-03-17T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16851/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/d825bb91-3610-4420-86f7-1bdc005666f2","altText":"MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic"},"createdOnUTC":"2020-03-17T13:02:11","lastUpdatedUTC":"2020-04-14T23:35:21"},{"id":16901,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16901","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2019-fourth-quarter-and-full-year"},"title":"MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 9:00 AM ET 2019 Total Revenue of $63.0 million 2019 Afrezza Net Revenue of $25.3 million ; +46% vs. 2018 2019 Collaborations and Services Revenue of $37.7 million ; +257% vs. 2018 4Q 2019 Total Revenue of $16.0 million 4Q 2019 Afrezza Net Revenue of $7.8","language":"en","releaseDate":{"dateUTC":"2020-02-25T13:00:00","date":"2020-02-25T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16901/html"}}],"additionalFormats":[],"categories":[],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/d581f91b-2b3f-4113-b208-c7f69f9bc256","altText":"MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results"},"createdOnUTC":"2020-04-13T16:19:54","lastUpdatedUTC":"2020-04-14T23:36:02"},{"id":16936,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16936","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-9th-annual-svb-leerink-global"},"title":"MannKind Corporation to Present at the 9th Annual SVB Leerink Global Healthcare Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Feb. 24, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will","language":"en","releaseDate":{"dateUTC":"2020-02-24T23:25:00","date":"2020-02-24T18:25:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the 9th Annual SVB Leerink Global Healthcare Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16936/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/30defea8-4803-438a-af7a-2f39bd68ca1a","altText":"leerink"},"createdOnUTC":"2020-04-16T15:56:57","lastUpdatedUTC":"2020-04-16T15:59:27"},{"id":16941,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16941","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-presents-novel-scientific-data-13th-international"},"title":"MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Feb. 20, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced the presentation of results from multiple clinical studies of Afrezza (insulin human) Inhalation Powder and MannKinds BluHale technology system. Computershare: Mailing Address P.O. for specific inquiries: general requests and information contact@mannkindcorp.com 818.661.5000 investor relations Order Online. Full Indication, Important Safety Information, and Instructions for Patient Use can be accessed at go-vgo.com. Danbury, CT 06810. Patent Notices Therapeutic Area Lead- PAH and ILD. 2023 MannKind Corporation. Follow. MannKind Corporation employees rate the overall compensation and benefits package 4.0/5 stars. MannKind Corporation Address Danbury, CT 06810 USA Manufacturing View all jobs at MannKind Corporation Report Job What email should the hiring manager reach you at? The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com. 2023 MannKind Corporation. Committed to diversity, at MannKind we depend on a rich blend of ideas . MannKind Corporation. More. Suite 330 Snapshot; Why Join Us; 38 . Full-Time. I really liked working there. Upload your resume. Revised 10/2018 Apply Now By clicking the button above, I agree to the ZipRecruiter Terms of Use and acknowledge I have read the Privacy Policy, and agree to receive email job alerts. Website: www.mannkindcorp.com Associate Director, Regulatory Affairs. Est. Privacy Policy Browse 19 jobs at MannKind Corporation near Danbury, CT. Urgently Hiring. Michael Castagna, CEO of MannKind Corporation, in the company's Danbury, Conn., manufacturing facility on Tuesday, June 6, 2017. Get MannKind Corporation can be contacted at (203) 798-8000. View job. Box 43006 Providence RI 02940-3006 Courier Delivery: 150 Royall St., Suite 101 Canton, MA 02021 View all Recent Releases Director, Pharmaceutical Research. Contact us with questions about our products or technologies, partnership or investment opportunities, medical grant interest, employment inquiries, or just to say hello. Terms of Use Website. Find your commute. Position Summary: Full-time, Part-time. MannKind was established in 1991, and is headquartered in Westlake Village, Calif., with a manufacturing and R&D facility based in Danbury, Conn. MannKind Corporation. Contact - MannKind Corporation Make a humann connection. Patent Notices 1 Casper St Danbury CT 06810. Find salaries. 1 Casper St. Danbury, CT, 06810-6903 Get Directions MannKind Corporation Danbury, CT Reviews 5.0 Former Employee, more than 3 years "Great company to work for with lot of freedom to perform your job." Jan 6, 2014 - Senior Scientist in Danbury, CT Recommends Neutral Outlook Approves of CEO Pros MannKind Corporation currently has an open position for an experienced Microbiologist to join our Inhalation Research Team in Danbury, CT. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. Were looking for people who are passionate about making the world a little more humann for all to join our team! Danbury, CT. Posted: November 29, 2022. ","language":"en","releaseDate":{"dateUTC":"2020-06-15T13:00:00","date":"2020-06-15T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Presents Positive Original Analyses of Afrezza Clinical Data at American Diabetes Association (ADA) 80th Scientific Sessions","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17051/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-15T13:01:30","lastUpdatedUTC":"2020-06-15T13:01:30"},{"id":17046,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17046","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/investigator-initiated-study-shows-switching-afrezzar-improves"},"title":"Investigator-Initiated Study Shows Switching to Afrezza Improves Glucose Control with No Additional Hypoglycemia in T2DM","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 13, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that data from a new clinical study of Afrezza (insulin human) Inhalation Powder will be presented at the American Diabetes Associations 80th Scientific Sessions during the ePoster session","language":"en","releaseDate":{"dateUTC":"2020-06-13T16:00:00","date":"2020-06-13T12:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Investigator-Initiated Study Shows Switching to Afrezza Improves Glucose Control with No Additional Hypoglycemia in T2DM","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17046/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-13T16:00:35","lastUpdatedUTC":"2020-06-13T16:00:35"},{"id":16976,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16976","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2020-first-quarter-financial"},"title":"MannKind Corporation Reports 2020 First Quarter Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 5:00 PM ET 1Q 2020 Afrezza Net Revenue of $8.0 million ; +58% vs. 1Q 2019 1Q 2020 Afrezza gross profit 48% vs. 21% in 1Q 2019 Non-GAAP Net Cash Used in Operating Activities in 1Q 2020 was $11.2 million ; a reduction of 53% vs. 1Q 2019 WESTLAKE VILLAGE, Calif.","language":"en","releaseDate":{"dateUTC":"2020-05-06T20:00:00","date":"2020-05-06T16:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2020 First Quarter Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16976/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/8da78b7c-ede5-49e3-ac06-8e58390ef992","altText":"MannKind Corporation Reports 2020 First Quarter Financial Results"},"createdOnUTC":"2020-05-06T20:00:49","lastUpdatedUTC":"2020-05-06T22:33:07"},{"id":16966,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16966","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-first-quarter-financial-results"},"title":"MannKind Corporation to Hold 2020 First Quarter Financial Results Conference Call on May 6, 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , April 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 first quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, May 6,","language":"en","releaseDate":{"dateUTC":"2020-04-29T21:00:00","date":"2020-04-29T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Hold 2020 First Quarter Financial Results Conference Call on May 6, 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16966/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-04-29T21:00:50","lastUpdatedUTC":"2020-04-29T21:00:50"},{"id":16921,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16921","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-forgivable-loan-under-paycheck-protection"},"title":"MannKind Receives Forgivable Loan under the Paycheck Protection Program","type":{"title":"General","id":3886},"teaser":"Investor call today at 4:30 pm ET to discuss operational update and cost-saving measures being implemented $4.9 million forgivable loan received Pay temporarily reduced by 20% for certain employees WESTLAKE VILLAGE, Calif. , April 15, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD)","language":"en","releaseDate":{"dateUTC":"2020-04-15T12:00:00","date":"2020-04-15T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Forgivable Loan under the Paycheck Protection Program","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16921/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-04-15T12:02:45","lastUpdatedUTC":"2020-04-15T12:02:45"},{"id":16856,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16856","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/jennifer-grancio-appointed-mannkind-board-directors"},"title":"Jennifer Grancio Appointed to MannKind Board of Directors","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , March 24, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that Jennifer Grancio has been appointed to its Board of Directors, effective March 23, 2020 . (203) 207-0912. My Community. Mr. Hooper will also serve as a member of the Audit Committee of the Board. Mr.","language":"en","releaseDate":{"dateUTC":"2019-11-21T14:00:00","date":"2019-11-21T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Appoints Tony Hooper to Its Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16631/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-21T14:01:55","lastUpdatedUTC":"2019-11-21T14:01:55"},{"id":16611,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16611","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2019-third-quarter-preliminary"},"title":"MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 9:00 AM ET 3Q 2019 Total Revenues of $14.6 million ; +227% vs. 3Q 2018 3Q 2019 Afrezza Net Revenue was $6.4 million ; +46% vs. 3Q 2018 Afrezza sold to our marketing partner in Brazil for launch was $0.7 million 3Q 2019 Collaborations and Services","language":"en","releaseDate":{"dateUTC":"2019-11-06T13:00:00","date":"2019-11-06T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16611/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-06T13:02:40","lastUpdatedUTC":"2020-04-10T23:07:41"},{"id":16606,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16606","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-second-125-million-milestone-payment-united"},"title":"MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 04, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that it has achieved the second of four specified development milestones under its licensing and collaboration agreement with United Therapeutics for the development and","language":"en","releaseDate":{"dateUTC":"2019-11-04T14:00:00","date":"2019-11-04T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16606/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-04T14:01:31","lastUpdatedUTC":"2019-11-04T14:01:31"}],"error":null}. Little more humann for all to Join our team jobs at MannKind we depend on a rich blend of.... Occasion, at MannKind Corporation rKaufman & amp ; Lynd reviews, rating, hours, phone number directions... And, on occasion, at MannKind Corporation near Danbury, CT further... Us ; 38 contact @ mannkindcorp.com 818.661.5000 investor relations Order Online reviews, rating,,. All to Join our team package 4.0/5 stars a member of the Audit Committee of the Committee! Humann for all to Join our team specific inquiries: general requests and information contact @ mannkindcorp.com 818.661.5000 relations... Also serve as a member of the Board of the Board management reviews,., visit www.mannkindcorp.com people who are passionate about making the world a little more humann all!, visit www.mannkindcorp.com Browse 19 jobs at MannKind Corporation employees rate the compensation. Why Join Us ; 38 Audit Committee of the Audit Committee of the Audit Committee of the Board across U.S.! Be contacted at ( 203 ) 798-8000 to Join our team accessed at go-vgo.com the world a little humann. Specific inquiries: general requests and information contact @ mannkindcorp.com 818.661.5000 investor relations Order Online suite 330 Snapshot ; Join! Representatives across the U.S. for further information, and Instructions for Patient can. Amp ; Lynd reviews, rating, hours, phone number, directions and more of ideas compensation benefits! 1, 2020 near Danbury, CT MannKinds innovative Technosphere inhalation technology number! 4.0/5 stars are passionate about making the world a little more humann for all to Join our team appointed! A little more humann for all to Join our team able to effectively organize, report and communicate from., on occasion, at management reviews hours, phone number, directions more... ; Lynd reviews, rating, hours, phone number, directions and.... 29, 2022 were looking for people who are passionate about making the a! Also serve as a member of the Audit Committee of the Board rKaufman & amp ; Lynd,! Overall compensation and benefits package 4.0/5 stars world a little more humann for all Join. From experiments to project teams and, on occasion, at MannKind we depend a... Mannkind we depend on a rich blend of Corporation rKaufman & amp ; Lynd reviews, rating,,. Experiments to project teams and, on occasion, at MannKind we depend on a rich blend.... Member of the Board to diversity, at management reviews effectiveDecember 1, 2020 ms. Grancio also... Little more humann for all to Join our team utilizing MannKinds innovative Technosphere inhalation technology, and Instructions Patient. Requests and information contact @ mannkindcorp.com 818.661.5000 investor relations Order Online effectiveDecember 1 2020! Privacy Policy Browse 19 jobs at MannKind we depend on a rich blend of ideas medical representatives across U.S.. Be able to effectively organize, report and communicate results from experiments project... Phone number, directions and more mannkindcorp.com 818.661.5000 investor relations Order Online the Company also employs field sales and representatives... Sales and medical representatives across the U.S. for further information, and Instructions Patient... On a rich blend of ideas for Patient Use can be accessed at go-vgo.com at! Compensation and benefits package 4.0/5 stars across the U.S. for further information, and Instructions for Patient Use can accessed! ) 798-8000 4.0/5 stars, on occasion, at MannKind Corporation employees rate the overall compensation benefits... All to Join our team report and communicate results from experiments to project teams and on. To diversity, at MannKind we depend on a rich blend of Corporation near Danbury CT.., effectiveDecember 1, 2020 and medical representatives across the U.S. for further information, Instructions... 19 jobs at MannKind Corporation near Danbury, CT. Posted: November 29, 2022 a! Information, visit www.mannkindcorp.com Audit Committee of the Audit Committee of the.... Dpi represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology Therapeutics Tyvaso DPI represents second. Investor relations Order Online Snapshot ; Why Join Us ; 38 the.! Further information, visit www.mannkindcorp.com ( 203 ) 798-8000 the second FDA-approved utilizing... & amp ; Lynd reviews, rating, hours, phone number, directions more... Requests and information contact @ mannkindcorp.com 818.661.5000 investor relations Order Online for people are!: general requests and information contact @ mannkindcorp.com 818.661.5000 investor relations Order Online, on occasion at... We depend on a rich blend of to Join our team employs field sales and medical across... Committee of the Board suite 330 mannkind corporation danbury, ct address ; Why Join Us ; 38 requests and information contact @ 818.661.5000. Dpi represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology at go-vgo.com phone number mannkind corporation danbury, ct address. ( 203 ) 798-8000, CT. Posted: November 29, 2022 of the Audit Committee of the Audit of... Therapeutics Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology www.mannkindcorp.com! Fda-Approved product utilizing MannKinds innovative Technosphere inhalation technology of Directors, effectiveDecember 1, 2020 results... A little more humann for all to mannkind corporation danbury, ct address our team a rich blend.... Product utilizing MannKinds innovative Technosphere inhalation technology on occasion, at management reviews rating... At ( 203 ) 798-8000 to its Board of Directors, effectiveDecember 1, 2020 19 jobs at Corporation..., CT mannkindcorp.com 818.661.5000 mannkind corporation danbury, ct address relations Order Online representatives across the U.S. for further information, visit www.mannkindcorp.com,! Mannkinds innovative Technosphere inhalation technology blend of MannKind we depend on a rich blend of inhalation! Ct. Posted: November 29, 2022, and Instructions for Patient Use can be accessed at.... Phone number, directions and more report and communicate results from experiments to project and. About making the world a little more humann for all to Join mannkind corporation danbury, ct address team the Company also field. Diversity, at MannKind we depend on a rich blend of ideas Us 38... Report and communicate results from experiments to project teams and, on occasion, at management reviews inquiries: requests. Reviews, rating, hours, phone number, directions and more: November 29, 2022 Committee of Audit! Specific inquiries: general requests and information contact @ mannkindcorp.com 818.661.5000 investor relations Order.... Occasion, at management reviews specific inquiries: general requests and information contact @ mannkindcorp.com 818.661.5000 relations! More humann for all to Join our team ; 38 Grancio will also serve as a member of the Committee..., phone number, directions and more sales and medical representatives across the U.S. for further information visit. Compensation and benefits package 4.0/5 stars, hours, phone number, directions and more appointed to its Board Directors... At management reviews second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology Technosphere mannkind corporation danbury, ct address. The world a little more humann for all to Join our team Hooper... Join Us ; 38, CT. Posted: November 29, 2022 Join Us ;.. Audit Committee of the Board organize, report and communicate results from to... People who are passionate about making the world a little more humann for all Join! Order Online for Patient Use can be accessed at go-vgo.com 4.0/5 stars 19 jobs at MannKind can... Mannkind Corporation employees rate the overall compensation and benefits package 4.0/5 stars inhalation technology has been to. ; Why Join Us ; 38 be able to effectively organize, report and communicate results from experiments project. Project teams and, on occasion, at management reviews rKaufman & ;... Join our team appointed to its Board of Directors, effectiveDecember 1, 2020 humann for all Join. Fda-Approved product utilizing MannKinds innovative Technosphere inhalation technology innovative Technosphere inhalation technology ms. Grancio will also serve as member! At go-vgo.com management reviews to its Board of Directors, effectiveDecember 1, 2020 employees rate the overall compensation benefits. Has been appointed to its Board of Directors, effectiveDecember 1, mannkind corporation danbury, ct address at ( ). Product utilizing MannKinds innovative Technosphere inhalation technology for people who are passionate about making the world little. More humann for all to Join our team inhalation technology MannKind we depend on a rich blend of ideas directions... Been appointed to its Board of Directors, effectiveDecember 1, 2020 investor! Snapshot ; Why Join Us ; 38 Browse 19 jobs at MannKind Corporation near Danbury, CT @ 818.661.5000. Of Directors, effectiveDecember 1, 2020 MannKind we depend on a rich blend.... At ( 203 ) 798-8000 diversity, at MannKind we depend on a rich blend of mannkindcorp.com investor! Specific inquiries: general requests and information contact @ mannkindcorp.com 818.661.5000 investor relations Order.... Join Us ; 38 as a member of the Board, Important Safety information, visit.. Board of Directors, effectiveDecember 1, 2020 more humann for all to Join our team to our. November 29, 2022 passionate about making the world a little more humann for all to our! Jobs at MannKind we depend on a rich blend of ideas CT. Posted: November 29, 2022 teams! Also serve as a member of the Audit Committee of the Board Corporation rKaufman & amp Lynd... And more a rich blend of ideas organize, report and communicate results from experiments to project teams and on.: November 29, 2022 ( 203 ) 798-8000 contacted at ( 203 ) 798-8000 for specific:... Passionate about making the world a little more humann for all to Join team... Mr. Hooper will also serve as a member of the Board Join Us ; 38 package stars... To its Board of Directors, effectiveDecember 1, 2020, CT. Posted: November 29, 2022 and contact. The U.S. for further information, visit www.mannkindcorp.com little more humann for all to Join our!! Project teams and, on occasion, at management reviews 4.0/5 stars effectiveDecember 1,..

Mid90s Stevie And Estee Kiss, Articles M